Tilray Medical launches medical cannabis in Panama

Product / TechRegulation
โดย GlobeNewswire·Read original
Summary · why it matters

Tilray Medical has commercially launched its first medical cannabis product in Panama, marking a significant step in its global expansion. The launch follows the shipment of Tilray Oral Solution CBD100 from the company’s EU-GMP-certified facilities in Portugal through a joint venture with Solana Life Group. The product will be distributed via Farmacias Arrocha, one of Panama’s leading pharmacy networks, and will be available to patients with a medical prescription. This move supports Panama’s medical cannabis framework under Law 242 of 2021 and recent regulatory advancements, including the introduction of a patient and caregiver identification system. Tilray Medical now serves patients in more than 20 countries across five continents.

Impact on stocks 1

Health Care▲ · 1 stocks
Tilray Inc
TLRY
▲ PositiveDemandrelevance

Tilray Medical launches medical cannabis in Panama, expanding patient access and revenue potential.

Off-coverage companies 2

Farmacias ArrochaPrivate▲ Positive
Demandrelevance

Farmacias Arrocha will distribute Tilray's product, potentially increasing pharmacy revenue.

Solana Life GroupPrivate▲ Positive
Demandrelevance

Solana Life Group's joint venture with Tilray facilitates market entry, benefiting from distribution.

© 2026 MarketDXNews